How efficacious is spa treatment? A systematic review of randomized studies;Urticaria pigmentosa und mastozytose

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 10, 1998, Pages 296-303

  Haase, I ^a   Grabbe, J ^a   Henz, B M ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001278514     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023951     Document Type: Article

References (46)

1. Bauchinger, M., J. Mezger:A case of malignant mastocytosis with near-haploid, near-diploid, and polyploid cells in the bone marrow. Cancer Genet. Cytogenet. 48 (1990). 13-21.
2. Butterfield, J. H.. G. Weiler, G. Dewald, G.J. Gleich:Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12 (1988), 345-355.
3. Büttner, C, I. Heide. N. Sepp, B. M. Henz. J. Grabbe:Identification of a c-kit mutation in adult- but not in childhood-onset mastocytosis. Arch. Derm.'Res. 289 (1997), A39.
4. t Cundy.'T., M. N. Beneton, A. J. Darby. W. J. Marshall, J. A. Kanis:Osteopenia in systemic mastocytosis:natural history and responses to treatment with inhibitors of bone résorption. Bone 8 (1987), 149-155.
5. s Czarnetzki, B. M.:Urticaria (Springer:Berlin 1986), 116-121.
6. Czarnetzki, B. M., H. Behrendt:Urticaria pigmentosa:clinical picture and response to oral disodium cromoglycate. Brit. J. Dermatol. 105 (1981), 563-567.
7. Czarnetzki, B. M.:A double-blind cross over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica 166 (1983), 4447.
8. s Czarnetzki, B. M.. G. Kolde, A. Schoemann, S. Urbanitz, D. Urbanitz:Bone marrow findings in adult patients with urticaria pigmentosa. J. Amer. Acad. Dermatol. 18 (1988), 45-51.
9. Czarnetzki, B. M..T. Rosenbach, G. Kolde, P.J. Frosch:Phototherapy of urticaria pigmentosa:clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes. Arch. Dermatol. Res. 277 (1985). 105-113.
10. Czarnetzki, B. M., B. Algermissen, S. Jeep, N. Haas, W. Nürnberg, K. Müller,]. D. Kropp:Interferon treatment of patients with chronic urticaria and mastocytosis. J. Amer. Acad. Dermatol. 30 (1994), 500-501.
11. Czarnetzki, B. M., J. Grabbe, G. Kolde, S. Kruger-Krasagakes, T. Zuberbier:Mast cells in the cytokine network - the what, where from and what for. Exp. Dermatol. 4 (1995), 221-226.
12. Delaporte, E., E. Pierard, B. G. Wolthers, P. Desreumaux, A. Janin. A. Cortot, F. Piette, H. Bergoend:Interferon alpha in combination with corticosteroids improves systemic mast cell disease. Brit. J. Dermatol. 132 (1995), 479-494.
13. Ehrlich, P.:Beiträge zur Kenntnis der Anilinfärbungen und ihrer Verwendung in der mikroskopischen Technik. Archiv der Mikroskopischen Anatomie 13 (1877), 263-277.
14. i" Furitsu,T.,T.Tsujimura,T.Tono, H. Ikeda, H. Kitayama.U. Koshimizu, H. Sugahara, J. H. Butterfield, L K. Ashman, Y. Kanayama, Y. Matsuzawa, Y. Kitamura, Y. Kanakura:Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.]. Clin. Invest. 92 (1993). 1736-1744.
15. Genovese, A., G. Sparado, M. Triggiani, G. Marone:Clinical advances in mastocytosis. Int.J. Clin. Lab. Res. 25 (1995). 178-188.
16. Grabbe, J., N. Haas. B. M. Czarnetzki:Die Mastzelle. Hautarzt 45 (1994), 55-64.
17. Gruchalla, R. S.:Southwestern internal medicine conference. Mastocytosis. Developments during the past decade. Amer. J. Med. Sei. 309 (1995), 328-338.
18. '8Hamann, K., N. Haas, J. Grabbe, B. M. Czarnetzki:Expression of stem cell factor in cutaneous mastocytosis. Brit. J. Dermatol. 133 (1995). 203-208.
19. is Henz. B. M., T. Zuberbier, J. Grabbe:Urtikaria-KIinik, Diagnostik, Therapie (Springer:Berlin 1996).
20. 2 Kettelhut, B. V., D. D. Metcalfe:Pédiatrie mastocytosis. Ann. Allergy 73 (1994), 197-202.
21. Kitamura, Y, M. Shimada, K. Hatanaka, Y. Miyano:Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 268 ( 1977), 442 - 443.
22. Kluin-Nelemans, H. C, J. H.Jansen, H. Breukelman, B. G. Wolthers, P. M. Kluin, H. M. Kroon, R. Willemze:Response to Interferon alfa 2 b in a patient with systemic mastocytosis. New Engl. J. Med. 326 (1992), 619-623.
23. Kolde, G., P. J. Frosch, B. M. Czarnetzki:Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa. Histomorphometric, ultrastructural, and biochemical investigations.]. Invest. Dermatol. 83 (1984), 175-178.
24. Kolde, G., C. Sunderkötter, T. A. Luger:Treatment of urticaria pigmentosa using interferon alpha. Brit. J. Dermatol. 133 (1995), 91-94.
25. Lehmann, T., C. Beyeler, B. Lammle, T. Hunziker, P. Vock, A. J. Olah, C. Dahinden, N. J. Gerber:Severe osteoporosis due to systemic mast cell disease. Successful treatment with interferon alpha-2 b. Brit.]. Rheumatol. 35 (1996), 898 -900.
26. Lippert, U., B. M. Henz:Long-term effect of interferon alpha treatment in mastocytosis. Brit.J. Dermatol. 134 (1996), 1164-1165.
27. Lishner, M., R. Confmo-Cohen, Y. A. Mekori, M. Feigin, Y. Manor, A. Goldberg, M. Ravid, A. Amiel:Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis. J. Allergy Clin. Immunol. 98 (1996), 199 -204.
28. Longley, B. J., G. S. Morganroth, L Tyrell.T. G. Ding, D. M. Anderson, D. E. Williams, R. Halaban:Altered metabolism of mast cell growth factor (c-kit ligand) in cutaneous mastocytosis. New Engl. J. Med. 328 (1993), 1302-1307.
29. Longley, B.J., LTyrell. S. Z. Lu. Y. S. Ma, K. Langley, T. G. Ding, T. Duffy. P.Jacobs, L H. Tang, I. Modlin:Somatic c-KlT activating mutation in urticaria pigmentosa and aggressive mastocytosis:establishment of donality in a human mast cell neoplasm. Nature Genetics 12 (1996), 312-314.
30. Metcalfe, D. D.:Classification and diagnosis of mastocytosis. Current status.]. Invest. Dermatol. 96 (1991), 2 S-4 S.
31. Metcalfe, D. D.:Conclusions of a roundtable discussion on mastocytosis. ]. Invest. Dermatol. 96 ( 1991 ), 64 S - 66 S.
32. Fricker, M., A. Helbling, L. Schwartz, U. Müller:Hymenoptera sting anaphylaxis and urticaria pigmentosa:clinical findings and results of venom immunotherapy in ten patients.]. Allergy clin. Immunol. 100 (1997), 11 -15.
33. Nagata, H., A. S. Worobec, C. K. Oh, B. A. Chowdhury. S. Tannenbaum, Y. Suzuki, D. D. Metcalfe:Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hématologie disorder. Proc. Natl. Acad. Sei. USA 92 (1995), 10560-10564.
34. Nettleship, E.. W.Tay:Rare forms of urticaria. Brit. Med. J. 2 (1869), 323-324.
35. Sangster, A.:An anomalous mottled rash, accompanied by pruritus, factitious urticaria and pigmentation:urticaria pigmentosa. Transactions of the Clinical Society of London 11 (1878), 161 -163.
36. Sezary, A., G. Levy-Coblentz, P. Chauvillon:Dermographisme et mastocytose. Bulletin de la Société Française de Dermatologie et de Syphiligraphie 43 (1936), 359 - 361.
37. Sondergaard, ]., G. Asboe-Hansen:Mastocytosis in childhood. In Happle, R., Grosshans, E. (Ed.):Pédiatrie Dermatology (Springer:Heidelberg 1987), 148-154.
38. Soter, N. A.:The skin in mastocytosis. J. Invest. Dermatol. 96 (1991),32S-39S.
39. Stege, H., E. Schöpf, T. Ruzicka, J. Krutmann:High dose UVA1 for urticaria pigmentosa. Lancet 347 (1996), 64.
40. Taylor, G., F. Wojnarowska, Y. Chia, C. Kennedy:Treatment of urticaria pigmentosa by corticosteroids applied under a hydrocolloid dressing. Europ.J. Dermatol. 3 (1993), 276-278.
41. Travis, W. D., C. Y. Li, E.J. Bergstrahl. L T. Yam, R. G. Swee:Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine 67 (1988), 345-368.
42. Unna, P. G.:Anatomie und Pathogenese der Urticaria simplex and pigmentosa. Monatsschrift der praktischen Dermatologie 6 (1887). EH1.
43. Webb. T. A., C. Y. Li. L T. Yam:Systemic mast cell disease:a clinical and hematopathologic study of 26 cases. Cancer (Philad.) 49 (1982), 927-938.
44. "i Weide, R.. K. Ehlenz, W. Lorenz, E. Walthers, M. Klausmann. K. H. Pflüger:Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b. Ann. Hematol. 72 (1996), 41-43.
45. Worobec, A. S., A. S. Kirshenbaum, L B. Schwartz, D. D. Metcalfe:Treatment of three patients with systemic mastocytosis with interferon alpha-2b. Leuk. Lymphoma 22 (1996), 501 -508.
46. Zhang, Y., B. Schlegelberger, K. Weber-Matthiesen, W. Grote, H. Bartels:Translocation (X;8)(q2?6,q21.3) in a case of systemic mastocytosis. Cancer Genet. Cytogenet. 78 (1994), 236-238.